Diekman, Eugene F <br/><br/>
Survival and psychomotor development with early betaine treatment in patients with severe methylenetetrahydrofolate reductase deficiency.  [electronic resource] 

 -  JAMA neurology  Feb 2014 
 - 188-94 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Meta-Analysis; Review 
<br/><br/><label>ISSN: </label>2168-6157 
<br/><br/><label>Standard No.: </label>10.1001/jamaneurol.2013.4915  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Betaine--administration & dosage<br/>Child<br/>Child, Preschool<br/>Female<br/>Homocystinuria--drug therapy<br/>Humans<br/>Infant<br/>Infant, Newborn<br/>Male<br/>Methylenetetrahydrofolate Reductase (NADPH2)--deficiency<br/>Muscle Spasticity--drug therapy<br/>Psychomotor Disorders--enzymology<br/>Psychotic Disorders--drug therapy<br/>Severity of Illness Index<br/>Survival Rate--trends<br/>Treatment Outcome<br/>Young Adult